The Scotts Miracle SMG
$58.60 −$2.12 (-3.49%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $58.60 0.00%
Open$61.19
Prev close$60.72
Day range$58.53 – $61.94
Volume928.6K
Market cap$3.41B
P/E (TTM)33.3
Dividend yield4.51%
Fundamentals
Latest reported quarter: Q4, ended Sep 2026
Revenue$302.90M-39.1% YoY
Operating profit-$144.80M-11.7% YoY
Net profit-$121.90M+19.7% YoY
Diluted EPS-$2.10+20.2% YoY
Free cash flow$146.30M+11.5% YoY
Operating cash flow$177.80M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin32.3%
Operating margin13.9%
Net margin3.2%
Return on assets3.8%
Current ratio1.22
Liabilities / assets113.6%
Cash & investments$7.40M
Total debt$2.03B
Net cash (debt)-$2.02B
Free cash flow / sales8.5%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 | 2026 Q1 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $3.29B | $302.90M | $1.17B | $1.46B | $354.40M |
| Total Operating Revenue | $3.29B | $302.90M | $1.17B | $1.46B | $354.40M |
| Cost of Revenue | $2.23B | $305.00M | $806.20M | $849.00M | $265.70M |
| Gross Profit | $1.06B | -$2.10M | $365.90M | $610.50M | $88.70M |
| Operating Expense | $607.10M | $142.70M | $149.30M | $206.50M | $108.70M |
| Selling and Admin Expenses | $594.70M | $144.00M | $136.90M | $191.20M | $95.50M |
| Other Operating Expenses | $12.40M | -$1.30M | $3.70M | $7.30M | $2.70M |
| Operating Profit | $455.90M | -$144.80M | $216.60M | $404.00M | -$20.00M |
| Net Non-Operating Interest Income (Expense) | -$112.60M | -$26.10M | -$28.00M | -$31.30M | -$27.20M |
| Non-Operating Interest Expense | $112.60M | $26.10M | $28.00M | $31.30M | $27.20M |
| Other Income (Expense) | -$65.30M | -$8.00M | -$33.40M | -$7.80M | -$16.10M |
| Earnings from Equity Interest | $3.00M | -$8.60M | $29.20M | -$4.50M | -$13.10M |
| Special Income (Charges) | -$49.20M | $1.80M | -$47.00M | -$2.20M | -$1.80M |
| -Less:Write Off | $49.20M | -$1.80M | $16.60M | – | – |
| Other Non-Operating Income (Expenses) | -$19.10M | -$1.20M | -$15.60M | -$1.10M | -$1.20M |
| Pretax Profit | $278.00M | -$178.90M | $155.20M | $364.90M | -$63.30M |
| Tax | $83.10M | -$54.70M | $51.60M | $101.60M | -$15.50M |
| Net Profit | $103.90M | -$121.90M | $112.20M | $238.60M | -$125.00M |
| Profit from Continuing Operations | $194.90M | -$124.20M | $103.60M | $263.30M | -$47.80M |
| Net Income from Discontinuous Operations | -$91.00M | $2.30M | $8.60M | -$24.70M | -$77.20M |
| Net Income to Parent Company | $103.90M | -$121.90M | $112.20M | $238.60M | -$125.00M |
| Net Income to Common Stockholders | $103.90M | -$121.90M | $112.20M | $238.60M | -$125.00M |
| Basic EPS | $1.79 | -$2.10 | $1.93 | $4.11 | -$2.16 |
| Diluted EPS | $1.76 | -$2.10 | $1.90 | $4.04 | -$2.16 |
| Dividend Per Share | $2.64 | $0.66 | $0.66 | $0.66 | $0.66 |
| -Selling & Marketing Expense | – | – | $64.70M | $81.20M | $21.10M |
| -General & Admin Expense | – | – | $72.20M | $110.00M | $74.40M |
| Research & Development | – | – | $8.00M | $7.30M | $9.80M |
| Depreciation & Amortization & Depletion | – | – | $700,000.00 | $700,000.00 | $700,000.00 |
| -Depreciation & Amortization | – | – | $700,000.00 | $700,000.00 | $700,000.00 |
| -Less:Restructuring and Mergern & Acquisition | – | – | $30.40M | $2.20M | $1.80M |
Balance sheet
| Line item | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 | 2026 Q1 |
|---|---|---|---|---|---|
| Total Assets | $2.74B | $2.74B | $3.17B | $3.41B | $3.03B |
| Total Current Assets | $863.00M | $863.00M | $1.35B | $1.62B | $1.26B |
| Cash and Cash Equivalents & Short-Term Investments | $7.40M | $7.40M | $27.70M | $6.20M | $8.30M |
| -Cash and Cash Equivalents | $7.40M | $7.40M | $27.70M | $6.20M | $8.30M |
| Receivables | $135.40M | $135.40M | $713.00M | $766.70M | $193.80M |
| -Accounts Receivable | $135.40M | $135.40M | $713.00M | $766.70M | $193.80M |
| Inventory | $577.90M | $577.90M | $481.40M | $696.00M | $846.70M |
| Other Current Assets | $142.30M | $142.30M | $127.00M | $124.50M | $147.40M |
| Total Non-Current Assets | $1.88B | $1.88B | $1.82B | $1.79B | $1.78B |
| Net PPE | $655.60M | $655.60M | $635.10M | $627.40M | $617.30M |
| Investments and Advances | $56.50M | $56.50M | $65.20M | $36.00M | $40.50M |
| -Long Term Equity Investment | $56.50M | $56.50M | $65.20M | $36.00M | $40.50M |
| Goodwill and Other Intangible Assets | $592.90M | $592.90M | $594.00M | $594.80M | $595.30M |
| -Goodwill | $243.90M | $243.90M | $243.90M | $243.90M | $243.90M |
| -Other Intangible Assets | $349.00M | $349.00M | $350.10M | $350.90M | $351.40M |
| Other Non-Current Assets | $574.20M | $574.20M | $524.00M | $531.90M | $523.70M |
| Total Liabilities | $3.11B | $3.11B | $3.38B | $3.70B | $3.53B |
| Total Current Liabilities | $709.10M | $709.10M | $1.11B | $1.28B | $932.40M |
| Payables | $244.90M | $244.90M | $310.30M | $385.80M | $283.90M |
| -Accounts Payable | $244.90M | $244.90M | $310.30M | $385.80M | $283.90M |
| Short-Term Debt and Capital Lease Obligation | $35.50M | $35.50M | $277.00M | $279.40M | $278.30M |
| -Current Debt | $35.50M | $35.50M | $277.00M | $279.40M | $278.30M |
| Other Current Liabilities | $428.70M | $428.70M | $523.50M | $610.40M | $370.20M |
| Total Non-Current Liabilities | $2.41B | $2.41B | $2.27B | $2.42B | $2.60B |
| Long Term Debt and Capital Lease Obligation | $1.99B | $1.99B | $1.84B | $2.07B | $2.25B |
| -Long Term Debt | $1.99B | $1.99B | $1.84B | $2.07B | $2.25B |
| Other Non-Current Liabilities | $413.50M | $413.50M | $429.00M | $354.50M | $352.00M |
| Total Equity | -$372.40M | -$372.40M | -$208.70M | -$286.50M | -$500.60M |
| Stockholders' Equity | -$372.40M | -$372.40M | -$208.70M | -$286.50M | -$500.60M |
| -Gross PPE | – | – | $1.50B | $1.48B | $1.45B |
| -Accumulated Depreciation | – | – | -$864.90M | -$850.60M | -$836.00M |
| Capital Stock | – | – | $350.10M | $346.30M | $346.90M |
| -Common Stock | – | – | $350.10M | $346.30M | $346.90M |
| Retained Earnings | – | – | $404.30M | $331.00M | $131.20M |
| Less: Treasury Stock | – | – | -$857.10M | -$858.80M | -$872.50M |
| Gains/Losses Not Affecting Retained Earnings | – | – | -$106.00M | -$105.00M | -$106.20M |
Cash flow
| Line item | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 | 2026 Q1 |
|---|---|---|---|---|---|
| Operating Cash Flow | $373.00M | $177.80M | $345.60M | $220.00M | -$370.40M |
| Net cash flow from continuing operations | $373.00M | $177.80M | $345.60M | $220.00M | -$370.40M |
| Net Income from Continuing Operations | $103.90M | -$121.90M | $112.20M | $238.60M | -$125.00M |
| Gain/Loss from Continuing Operations | $103.20M | $13.00M | $72.60M | -$100.30M | $117.90M |
| Depreciation & Depletion & Amortization | $67.90M | $16.70M | $16.70M | $16.10M | $18.40M |
| Deferred Tax | $70.40M | -$44.90M | $145.10M | -$6.90M | -$22.90M |
| Other Non-Cash Items | -$200,000.00 | $6.50M | -$138.30M | $135.90M | -$4.30M |
| Change in Working Capital | -$47.40M | $302.90M | $94.70M | -$82.50M | -$362.50M |
| -Change in Receivables | $27.40M | $579.50M | $51.80M | -$573.60M | -$30.30M |
| -Change in Inventory | -$35.90M | -$97.00M | $211.60M | $150.40M | -$300.90M |
| -Change in Prepaid Assets | -$12.40M | -$9.80M | $2.80M | $22.30M | -$27.70M |
| -Change in Payables and Accrued Expense | $8.10M | -$75.60M | -$77.60M | $98.20M | $63.10M |
| -Change in Other Current Liabilities | -$33.40M | -$73.00M | -$93.00M | $215.10M | -$82.50M |
| -Change In Other Working Capital | -$1.20M | -$21.20M | -$900,000.00 | $5.10M | $15.80M |
| Net cash flow from investing | -$125.90M | -$23.80M | -$56.70M | -$23.60M | -$21.80M |
| Net Cash Flow from Continuing Investing Activities | -$125.90M | -$23.80M | -$56.70M | -$23.60M | -$21.80M |
| Net PPE Purchase and Sale | -$77.60M | -$14.50M | -$24.50M | -$18.60M | -$20.00M |
| Net Business Purchase and Sale | -$35.00M | $0.00 | – | – | – |
| Net Other Investing Changes | -$13.30M | -$9.30M | $2.80M | -$5.00M | -$1.80M |
| Financing Cash Flow | -$276.40M | -$174.60M | -$270.00M | -$198.60M | $366.80M |
| Net Cash Flow from Continuing Financing Activities | -$276.40M | -$174.60M | -$270.00M | -$198.60M | $366.80M |
| Net Issuance Payments Of Debt | -$80.70M | -$86.40M | -$235.30M | -$181.50M | $422.50M |
| Net Common Stock Issuance | -$37.70M | -$25.60M | -$500,000.00 | -$3.30M | -$8.30M |
| Cash Dividends Paid | -$154.80M | -$38.50M | -$38.50M | -$39.50M | -$38.30M |
| Proceeds from Stock Option Exercised | $5.60M | $1.70M | $600,000.00 | $2.60M | $700,000.00 |
| Net Other Financing Charges | -$8.80M | -$25.80M | $3.70M | $23.10M | -$9.80M |
| Ending Cash Balance | $7.40M | $7.40M | $27.70M | $6.20M | $8.30M |
| Net Change in Cash | -$29.30M | -$20.60M | $18.90M | -$2.20M | -$25.40M |
| Beginning Cash Balance | $32.80M | $27.70M | $6.20M | $8.30M | $32.80M |
| Effect of Exchange Rate Changes | $100,000.00 | $300,000.00 | -$300,000.00 | $0.00 | $100,000.00 |
| Free Cash Flow | $278.40M | $146.30M | $321.10M | $201.40M | -$390.40M |
No comments yet — be the first to weigh in on SMG.
Sign in to join the discussion.